Akari Therapeutics, Plc (AKTX)

NASDAQ: AKTX · IEX Real-Time Price · USD

1.190

0.00 (0.00%)

At close: Apr 25, 2024, 3:56 PM

1.170

-0.020 (-1.68%)

After-hours: Apr 25, 2024, 4:00 PM EDT

Akari Therapeutics, Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2010
Net Income	-10.01	-17.75	-17.42	-17.08	-16.85	-20.5	-35.4	-18.14	-45.32	-1.95	Upgrade
Depreciation & Amortization	0	0	0	0.01	0.02	0.04	0.04	0.04	0.01	0	Upgrade
Share-Based Compensation	1.15	0.74	0.31	0.33	1.05	1.65	2.73	3.93	1.79	0	Upgrade
Other Operating Activities	-7.58	-4.5	-1.74	-0.2	2.86	-3.96	1.02	-10.46	38.55	0.47	Upgrade
Operating Cash Flow	-16.43	-21.5	-18.85	-16.95	-12.92	-22.77	-31.6	-24.62	-4.97	-1.48	Upgrade
Capital Expenditures	0	0	0	0	0	0	-0.04	-0.05	-0.01	0	Upgrade
Acquisitions	0	0	0	0	0	0	0	0	1.41	0	Upgrade
Change in Investments	0	0	0	0	0	0	10.02	-10.02	0	0	Upgrade
Other Investing Activities	-	-	-	-	-	-	-	0.01	-0.01	-	Upgrade
Investing Cash Flow	0	0	0	0	0	0	9.99	-10.07	1.39	0	Upgrade
Share Issuance / Repurchase	7.02	25.29	14.29	25.07	12.65	0.5	15.67	0	75	3.8	Upgrade
Debt Issued / Paid	0	0	0	0	0	0	0	0	-0.53	0.43	Upgrade
Other Financing Activities	-	-	-	-	-	-	-	-	-5.43	-	Upgrade
Financing Cash Flow	7.02	25.29	14.29	25.07	12.65	0.5	15.67	0	69.04	4.24	Upgrade
Exchange Rate Effect	0.01	0.11	-0.14	0.2	0.03	-0.01	-0.05	-0.13	0.12	0.02	Upgrade
Net Cash Flow	-9.41	3.89	-4.69	8.32	-0.24	-22.28	-5.99	-34.82	65.59	2.77	Upgrade
Free Cash Flow	-16.43	-21.5	-18.85	-16.95	-12.92	-22.77	-31.64	-24.68	-4.98	-1.48	Upgrade
Free Cash Flow Per Share	-3.36	-6.89	-8.78	-10.73	-14.11	-29.57	-50.73	-41.91	-11.68	-34.54	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).